These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 215196)

  • 21. Sodium inhibits both adenylate cyclase and high-affinity 3H-labeled p-aminoclonidine binding to alpha 2-adrenergic receptors in purified human platelet membranes.
    Mooney JJ; Horne WC; Handin RI; Schildkraut JJ; Alexander RW
    Mol Pharmacol; 1982 May; 21(3):600-8. PubMed ID: 6287197
    [No Abstract]   [Full Text] [Related]  

  • 22. Alpha-adrenergic receptor function in schizophrenia, affective disorders and some neurological diseases.
    Kafka MS; van Kammen DP; Kleinman JE; Nurnberger JI; Siever LJ; Uhde TW; Polinsky RJ
    Commun Psychopharmacol; 1980; 4(6):477-86. PubMed ID: 6271498
    [No Abstract]   [Full Text] [Related]  

  • 23. Characterization of alpha 2-adrenergic receptors in human platelets by binding of a radioactive ligand [3H]yohimbine.
    Mukherjee A
    Biochim Biophys Acta; 1981 Aug; 676(2):148-54. PubMed ID: 6114754
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterisation of human platelet adrenoceptors.
    Barnett DB; Swart SS; Nahorski SR; Cook N
    Adv Exp Med Biol; 1985; 192():97-108. PubMed ID: 2871708
    [No Abstract]   [Full Text] [Related]  

  • 25. Apparent "down-regulation" of human platelet alpha 2-adrenergic receptors is due to retained agonist.
    Karliner JS; Motulsky HJ; Insel PA
    Mol Pharmacol; 1982 Jan; 21(1):36-43. PubMed ID: 6127620
    [No Abstract]   [Full Text] [Related]  

  • 26. alpha-Adrenergic receptors in rat parotid cells. II. Desensitization of receptor binding sites and potassium release.
    Strittmatter WJ; Davis JN; Lefkowitz RJ
    J Biol Chem; 1977 Aug; 252(15):5478-82. PubMed ID: 195951
    [No Abstract]   [Full Text] [Related]  

  • 27. Catecholamine action on thyroid adenylate cyclase: evidence for inhibitory alpha-adrenoreceptors.
    Desmedt DH
    Biochem Pharmacol; 1980 Jul; 29(13):1966-8. PubMed ID: 6249327
    [No Abstract]   [Full Text] [Related]  

  • 28. Platelet function in essential thrombocythemia. Decreased epinephrine responsiveness associated with a deficiency of platelet alpha-adrenergic receptors.
    Kaywin P; McDonough M; Insel PA; Shattil SJ
    N Engl J Med; 1978 Sep; 299(10):505-9. PubMed ID: 210377
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evidence for high and low affinity alpha 2-receptors. Comparison of [3H]norepinephrine and [3H]phentolamine binding to human platelet membranes.
    Lynch CJ; Steer ML
    J Biol Chem; 1981 Apr; 256(7):3298-303. PubMed ID: 6259160
    [No Abstract]   [Full Text] [Related]  

  • 30. Regulation of adrenergic stimulation of hepatic adenylate cyclase by divalent cations.
    Jackowski MM; Johnson RA; Exton JH
    Biochim Biophys Acta; 1982 Jan; 714(1):74-83. PubMed ID: 6275906
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Variations in circulating catecholamines fail to alter human platelet alpha-2-adrenergic receptor number or affinity for [3H]yohimbine or [3H]dihydroergocryptine.
    Pfeifer MA; Ward K; Malpass T; Stratton J; Halter J; Evans M; Beiter H; Harker LA; Porte D
    J Clin Invest; 1984 Sep; 74(3):1063-72. PubMed ID: 6088579
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular mechanisms involved in alpha-adrenergic responses.
    Exton JH
    Mol Cell Endocrinol; 1981 Sep; 23(3):233-64. PubMed ID: 6269923
    [No Abstract]   [Full Text] [Related]  

  • 33. Binding of [3H]-dihydroergocryptine to alpha-adrenoceptors on intact human platelets [proceedings].
    Boullin DJ; Elliott JM
    Br J Pharmacol; 1979 May; 66(1):89P-90P. PubMed ID: 222386
    [No Abstract]   [Full Text] [Related]  

  • 34. Estrogen treatment decreases alpha-adrenergic binding sites on rabbit platelets.
    Roberts JM; Goldfien RD; Tsuchiya AM; Goldfien A; Insel PA
    Endocrinology; 1979 Mar; 104(3):722-8. PubMed ID: 220019
    [No Abstract]   [Full Text] [Related]  

  • 35. Age-associated increments in human platelet alpha-adrenoceptor capacity. Possible mechanism for platelet hyperactivity to epinephrine in aging man.
    Yokoyama M; Kusui A; Sakamoto S; Fukuzaki H
    Thromb Res; 1984 May; 34(4):287-95. PubMed ID: 6330925
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of alpha 2-adrenergic receptors on human platelets using [3H]yohimbine.
    Motulsky HJ; Shattil SJ; Insel PA
    Biochem Biophys Res Commun; 1980 Dec; 97(4):1562-70. PubMed ID: 6260094
    [No Abstract]   [Full Text] [Related]  

  • 37. Studies of alpha 2-adrenergic receptors of intact and functional washed human platelets by binding of 3H-dihydroergocryptine and 3H-yohimbine--correlation of 3H-yohimbine binding with the potentiation by adrenaline of ADP-induced aggregation.
    Lanza F; Cazenave JP
    Thromb Haemost; 1985 Aug; 54(2):402-8. PubMed ID: 3001964
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Different sedimentation properties of agonist- and antagonist-labelled platelet alpha 2 adrenergic receptors.
    Michel T; Hoffman BB; Lefkowitz RJ; Caron MG
    Biochem Biophys Res Commun; 1981 Jun; 100(3):1131-6. PubMed ID: 6268079
    [No Abstract]   [Full Text] [Related]  

  • 39. High affinity platelet alpha 2-adrenergic receptor density is decreased in older humans.
    Supiano MA; Hogikyan RV
    J Gerontol; 1993 Sep; 48(5):B173-9. PubMed ID: 8103534
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dihydroergocryptine binding and alpha-adrenoreceptors in smooth muscle.
    Kunos G; Hoffman B; Kwok YN; Kan WH; Mucci L
    Nature; 1979 Mar; 278(5701):254-6. PubMed ID: 218110
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.